Quantcast
Home » Topics » malaria vaccine

New malaria vaccine that cuts cases in half in trial could save millions of African children

Drug maker GlaxoSmithKline (GSK) said on Tuesday it hoped to get the green light for a prototype vaccine against malaria after trials showed it offered children a partial shield against the disease. Results for the Phase III stage of the closely-followed RTS,S vaccine were unveiled at a conference in Durban,…

Long term trials reveal promising malaria vaccine stops working after 4 years

A new vaccine that has raised hopes of becoming a potent new tool in the battle against malaria seems to stop working in children after four years, according to research published Wednesday. The vaccine candidate — known as RTS,S — is not yet on the market, but ongoing trials in…

Google+